This compound is primarily utilized in the pharmaceutical and biotechnology industries as a key intermediate in the synthesis of more complex molecules. It is often employed in the development of active pharmaceutical ingredients (APIs), particularly those targeting neurological disorders or inflammatory conditions, due to its structural features that can interact with specific biological targets. Its trifluoromethoxy and tert-butoxycarbonyl (Boc) groups make it a versatile building block in peptide synthesis and drug discovery, enabling the creation of compounds with enhanced stability and bioavailability. Additionally, it is used in research settings to study enzyme interactions and receptor binding mechanisms, contributing to the design of novel therapeutic agents.